chartexchange

VALN
Valneva SE
stockNASDAQADR

Market OpenNov 18, 2026 3:54:35 PM EST
5.43USD+1.592%(+0.09)1,263
4.6000Bid6.3300Ask1.7300Spread
Loading…
Loading…
500.56M
Healthcare
Biotechnology
HQ
Saint-Herblain, Pays De La Loire, France
Previous Close
$5.34
Beta
0.59
52-Week High
$12.18 2026-02-24
52-Week Low
$4.75 2026-07-24
SMA 50
$5.89
SMA 200
$6.56
Avg. Vol 10D
12,782
Avg. Vol 30D
16,423
Avg. Vol 90D
59,900
Relative Vol
0.08
85.71M
3.2600%
2,000
Nov 24, 2026 (5d)
VALN Profile

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States.

VALN Performance
PeriodPriceDateChangeBeta
1W5.762026-11-12-8.65%-1.773
1M5.512026-10-19-4.50%0.813
3M6.842026-08-19-23.07%0.725
6M5.762026-05-19-8.65%0.634
1Y8.702025-11-19-39.52%0.594
2Y4.562024-11-19+15.39%—
5Y48.912021-11-19-89.24%0.063
VALN Stock Summary

Valneva SE (NASDAQ:VALN) stock price today is $5.26, and today's volume is 1,259. VALN is down 1.461% today. The 30 day average volume is 16,423. VALN market cap is $500.56M with 95.13M shares outstanding.